Citadel Advisors
CLLS

Citadel Advisors’s Cellectis CLLS Stock Holding History

Citadel Advisors’s Portfolio CLLS Stock Details CLLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-1,700
Closed -$3.06K – 14584
2024
Q4 		$3.06K Buy
1,700
+300
+21% +$560 ﹤0.01% 14028
2024
Q3 		$3K Buy
1,400
+300
+27% +$652 ﹤0.01% 13701
2024
Q2 		$2.06K Buy
+1,100
New +$2.89K ﹤0.01% 13739
2024
Q1 		– Sell
-1,400
Closed -$4.31K – 14639
2023
Q4 		$4.31K Buy
1,400
+600
+75% +$1.42K ﹤0.01% 13516
2023
Q3 		$1.26K Sell
800
-300
-27% -$586 ﹤0.01% 13888
2023
Q2 		$2.17K Buy
+1,100
New +$2.11K ﹤0.01% 13817
2023
Q1 		– Sell
-1,500
Closed -$3.15K – 14800
2022
Q4 		$3.15K Buy
+1,500
New +$3.4K ﹤0.01% 14245
2022
Q1 		– Sell
-10,000
Closed -$81K – 13682
2021
Q4 		$81K Sell
10,000
-2,400
-19% -$23.6K ﹤0.01% 12928
2021
Q3 		$156K Sell
12,400
-7,200
-37% -$99.7K ﹤0.01% 12330
2021
Q2 		$303K Sell
19,600
-13,200
-40% -$222K ﹤0.01% 11240
2021
Q1 		$663K Buy
+32,800
New +$811K ﹤0.01% 9064
2019
Q3 		– Sell
-10,100
Closed -$158K – 9209
2019
Q2 		$158K Buy
+10,100
New +$180K ﹤0.01% 8328
2018
Q3 		– Sell
-9,300
Closed -$263K – 9245
2018
Q2 		$263K Buy
+9,300
New +$277K ﹤0.01% 7431

Other funds holding CLLS

BGI
B Group Inc Dallas, Texas $213M AUM 96.05% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.91B AUM 12.68% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Citadel Advisors's CLLS Position: Q2 2026 in Review

Citadel Advisors sold out of Cellectis (CLLS) in Q2 2026, closing a stake of 44,315 shares — an estimated $140K sold.

Citadel Advisors first reported a position in CLLS in Q1 2015 and held it in 40 quarters. The position peaked at $8.53M in Q4 2019. 27 funds tracked by Wall St. Rank hold CLLS as of Q2 2026.

  • Citadel Advisors reported no remaining Cellectis position as of Q2 2026 after selling out during the quarter.
  • Citadel Advisors sold 44,315 Cellectis shares in Q2 2026, an estimated $140K.
  • Citadel Advisors first reported a position in Cellectis in Q1 2015 and held it in 40 quarters.
  • Citadel Advisors's Cellectis position peaked at $8.53M in Q4 2019.
  • 27 funds tracked by Wall St. Rank held Cellectis as of Q2 2026.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.